Search Results 451-460 of 18186 for Crohns disease
Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects With Moderate to Severe Crohn's ...
... and Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Factitious disorder in Crohn's disease: Recurrent pancytopenia caused by surreptitious ingestion of 6-mercaptopurine. Case Reports in Gastroenterology. 2015 ...
... inflammatory bowel disease (IBD). Due to confounding factors for which it is difficult to control, including diet, medications and disease activity, it's ...
Focus Areas. The Immuno-Epigenetics Lab team has several projects studying the pathophysiology of inflammatory bowel disease (IBD) and how the immune system ...
Dancing through complex cancer, Crohn's disease care during COVID · A ... and providing compassion, expertise and answers to everyone who needs healing.
Adalimumab-afzb injection is also used to treat moderate to severe active Crohn's disease. It is also used to treat moderate to severe ulcerative colitis in ...
Type 2 AIP seems to affect only the pancreas, although about one-third of people with type 2 AIP have associated inflammatory bowel disease. Type 1 AIP can be ...
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic. Give Today · Find a doctor · Explore careers.
Do you have a history of intestinal problems such as ulcerative colitis, Crohn's disease or other inflammatory bowel disease? Have you been around anyone ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.